Tomefa E Asempa

27PUBLICATIONS
20CO-AUTHORS
Medical infection agents (incl. prions)Emergency medicineBioremediationMedical bacteriologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Mar 23, 2026
Antimicrobial activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025).

Elizabeth Cyr, Jill Argotsinger, Eric T Beck

|Sep 02, 2025
An antibiotic stewardship initiative focused on community-acquired bacterial pneumonia (CABP) in outpatient clinics and urgent care centers: a 2023-2024 community health system experience.

Tomefa E Asempa, Tyler Ackley, Kristin E Linder

|Aug 12, 2025
In vivo activity of ceftibuten-ledaborbactam oral combination against serine-β-lactamase-producing Enterobacterales: an assessment in the pyelonephritis and cystitis murine model.

Christina Koenig, Fan Yi, David P Nicolau

|Jul 17, 2025
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against Acinetobacter baumannii-calcoaceticus complex strains isolated from respiratory and bloodstream sources: results from ACNBio study.

Ecem Buyukyanbolu, Jill Argotsinger, Eric T Beck

|Apr 03, 2025
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022-2024).

Aliaa Fouad, April M Bobenchik, Robin Chamberland

|Oct 22, 2024
Validation of Cefiderocol Package Insert Dosing Recommendation for Patients Receiving Continuous Renal Replacement Therapy: A Prospective Multicenter Pharmacokinetic Study.

Aliaa Fouad, Emir Kobic, Nelson P Nicolasora

Pageof 5

Frequent Collaborators

12 joint publications

David P Nicolau

8 joint publications

Yasmeen Abouelhassan

3 joint publications

Patricia J Simner

3 joint publications

Holly K Huse